Claudio Cavazza is 10% at SCICLONE PHARMACEUTICALS INC (SCLN). They have made 23 open-market trades across 5 companies since 2006, most recently 2011-01-05.
CIK 0001164803
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
23 open-market purchases totalling $16.8M since 2006, never a sale. Across 15 scored buys the stock is down 4.8% at ninety days, and 5.1 points behind the S&P over the same stretch.
15 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 0% |
| Avg Move | -15.5% | -4.8% | -4.8% |
| Alpha | -10.9% | -5.1% | -5.1% |
| Scored | 15 | 15 | 15 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RGRX.OB | BUY | 2011-01-05 | 2011-01-07 | $0.27 | $600K | N/A | N/A | N/A |
| SNGX | BUY | 2010-06-18 | 2010-06-21 | $0.21 | $1.8M | -12.8% | -21.0% | -21.0% |
| DORB | BUY | 2009-09-24 | 2009-09-28 | $0.25 | $988K | N/A | N/A | N/A |
| RGN | BUY | 2009-06-02 | 2009-06-04 | $0.40 | $125K | N/A | N/A | N/A |
| DORB | BUY | 2009-02-11 | 2009-02-13 | $0.18 | $4.5M | N/A | N/A | N/A |
| RGN | BUY | 2008-12-10 | 2008-12-19 | $1.45 | $1.5M | N/A | N/A | N/A |
| RGN | BUY | 2008-02-29 | 2008-03-03 | $1.00 | $2.5M | N/A | N/A | N/A |
| SCLN | BUY | 2008-01-30 | 2008-02-01 | $2.05 | $59K | -15.6% | -3.7% | -3.7% |
| SCLN | BUY | 2008-01-28 | 2008-01-30 | $2.05 | $820 | -15.6% | -3.7% | -3.7% |
| SCLN | BUY | 2008-01-24 | 2008-01-28 | $2.04 | $74K | -15.6% | -3.7% | -3.7% |
| SCLN | BUY | 2008-01-22 | 2008-01-24 | $2.01 | $59K | -15.6% | -3.7% | -3.7% |
| SCLN | BUY | 2008-01-15 | 2008-01-17 | $2.01 | $127K | -15.6% | -3.7% | -3.7% |
| SCLN | BUY | 2008-01-14 | 2008-01-24 | $2.00 | $400 | -15.6% | -3.7% | -3.7% |
| SCLN | BUY | 2008-01-11 | 2008-01-15 | $2.00 | $57K | -15.6% | -3.7% | -3.7% |
| SCLN | BUY | 2007-11-13 | 2007-11-15 | $2.04 | $111K | -15.6% | -3.7% | -3.7% |
| SCLN | BUY | 2007-11-05 | 2007-11-07 | $2.05 | $83K | -15.6% | -3.7% | -3.7% |
| SCLN | BUY | 2007-11-01 | 2007-11-05 | $2.05 | $111K | -15.6% | -3.7% | -3.7% |
| SCLN | BUY | 2007-10-19 | 2007-10-23 | $2.05 | $51K | -15.6% | -3.7% | -3.7% |
| SCLN | BUY | 2007-10-17 | 2007-10-19 | $2.05 | $85K | -15.6% | -3.7% | -3.7% |
| SCLN | BUY | 2007-10-15 | 2007-10-17 | $2.06 | $144K | -15.6% | -3.7% | -3.7% |
| SCLN | BUY | 2007-10-01 | 2007-10-03 | $1.95 | $47K | -15.6% | -3.7% | -3.7% |
| RGN | BUY | 2006-12-21 | 2006-12-22 | $1.80 | $1.5M | N/A | N/A | N/A |
| RGN | BUY | 2006-03-06 | 2006-03-08 | $2.81 | $2.2M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.